ALLMedicine™ Tuberculosis Center
Research & Reviews 60,017 results
https://doi.org/10.1093/cid/ciab304
Clinical Infectious Diseases : an Official Publication Of... Hwang H, Kang H et. al.
Apr 10th, 2021 - Since September 1, 2016, bedaquiline and delamanid have been administered for treatment of patients with multidrug-resistant/rifampicin-resistant tuberculosis after the official approval in South Korea. This study aimed to assess and compare the f...
https://doi.org/10.1002/cpt.2261
Clinical Pharmacology and Therapeutics; Peloquin CA, Davies GR
Apr 10th, 2021 - Tuberculosis (TB) remains a leading cause of infectious death worldwide, and poverty is a major driver. Clinically, TB presents as "latent" TB and active TB disease, and the treatment for each is different. TB drugs can display "early bactericidal...
https://doi.org/10.1183/13993003.00361-2021
The European Respiratory Journal; Viney K, Linh NN et. al.
Apr 9th, 2021 - New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization.|2021|Viney K,Linh NN,Gegia M,Zignol M,Glaziou P,|
https://doi.org/10.21037/apm-20-1809
Annals of Palliative Medicine; Cheng LP, Gui XW et. al.
Apr 9th, 2021 - This study aimed to investigate the value of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) guided purulence aspiration and local isoniazid injection after lymph node puncture in the treatment of refractory mediastina...
https://doi.org/10.1186/s12879-021-06024-8 10.1016/S0140-6736(13)62639-2 10.1128/AAC.01035-15 10.1016/j.ijantimicag.2013.12.007 10.1016/j.ijantimicag.2014.09.012 10.1371/journal.pone.0032976 10.1183/13993003.01633-2017 10.21037/jtd.2019.11.03 10.1016/j.diagmicrobio.2012.03.025 10.1093/jac/dkm054 10.1093/jac/dkm038 10.1128/AAC.00036-08 10.1093/jac/dki353 10.1371/journal.pone.0102135 10.1128/AAC.06227-11 10.1128/AAC.00308-15 10.1016/j.tube.2018.04.008 10.1073/pnas.0508392103
BMC Infectious Diseases; Zheng H, He W et. al.
Apr 9th, 2021 - To explore the drug susceptibility of levofloxacin (LFX), moxifloxacin (MFX), bedaquiline (BDQ), linezolid (LZD), clofazimine (CFZ) and delamanid (DLM) against multidrug resistant tuberculosis (MDR-TB) isolates from drug resistance survey of south...
Guidelines 127 results
https://www.cdc.gov/mmwr/volumes/70/wr/mm7012a1.htm
MMWR Morb Mortal Wkly; Deutsch-Feldman M, Pratt RH et. al.
Mar 25th, 2021 - Tuberculosis (TB) disease incidence has decreased steadily since 1993 (1), a result of decades of work by local TB programs to detect, treat, and prevent TB disease and transmission. During 2020, a total of 7,163 TB cases were provisionally report...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045826
Emerging Infectious Diseases; Campbell JR, Falzon D et. al.
Jan 10th, 2020 - International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which...
https://www.atsjournals.org/doi/full/10.1164/rccm.201909-1874ST
American Journal of Respiratory and Critical Care Medicine; Payam Nahid et al
Nov 20th, 2019 - The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857485
American Journal of Respiratory and Critical Care Medicine; Nahid P, Mase SR et. al.
Nov 15th, 2019 - Background: The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant t...
https://www.nejm.org/doi/full/10.1056/NEJMoa1909953
The New England Journal of Medicine; Tait,D.,et al
Oct 28th, 2019 - BACKGROUND Results of an earlier analysis of a trial of the M72/AS01E candidate vaccine against Mycobacterium tuberculosis showed that in infected adults, the vaccine provided 54.0% protection against active pulmonary tuberculosis disease, without...
Drugs 249 results see all →
Clinicaltrials.gov 61,577 results
https://doi.org/10.1093/cid/ciab304
Clinical Infectious Diseases : an Official Publication Of... Hwang H, Kang H et. al.
Apr 10th, 2021 - Since September 1, 2016, bedaquiline and delamanid have been administered for treatment of patients with multidrug-resistant/rifampicin-resistant tuberculosis after the official approval in South Korea. This study aimed to assess and compare the f...
https://doi.org/10.1002/cpt.2261
Clinical Pharmacology and Therapeutics; Peloquin CA, Davies GR
Apr 10th, 2021 - Tuberculosis (TB) remains a leading cause of infectious death worldwide, and poverty is a major driver. Clinically, TB presents as "latent" TB and active TB disease, and the treatment for each is different. TB drugs can display "early bactericidal...
https://doi.org/10.1183/13993003.00361-2021
The European Respiratory Journal; Viney K, Linh NN et. al.
Apr 9th, 2021 - New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization.|2021|Viney K,Linh NN,Gegia M,Zignol M,Glaziou P,|
https://doi.org/10.21037/apm-20-1809
Annals of Palliative Medicine; Cheng LP, Gui XW et. al.
Apr 9th, 2021 - This study aimed to investigate the value of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) guided purulence aspiration and local isoniazid injection after lymph node puncture in the treatment of refractory mediastina...
https://doi.org/10.1186/s12879-021-06024-8 10.1016/S0140-6736(13)62639-2 10.1128/AAC.01035-15 10.1016/j.ijantimicag.2013.12.007 10.1016/j.ijantimicag.2014.09.012 10.1371/journal.pone.0032976 10.1183/13993003.01633-2017 10.21037/jtd.2019.11.03 10.1016/j.diagmicrobio.2012.03.025 10.1093/jac/dkm054 10.1093/jac/dkm038 10.1128/AAC.00036-08 10.1093/jac/dki353 10.1371/journal.pone.0102135 10.1128/AAC.06227-11 10.1128/AAC.00308-15 10.1016/j.tube.2018.04.008 10.1073/pnas.0508392103
BMC Infectious Diseases; Zheng H, He W et. al.
Apr 9th, 2021 - To explore the drug susceptibility of levofloxacin (LFX), moxifloxacin (MFX), bedaquiline (BDQ), linezolid (LZD), clofazimine (CFZ) and delamanid (DLM) against multidrug resistant tuberculosis (MDR-TB) isolates from drug resistance survey of south...
News 1,621 results
https://www.medscape.com/viewarticle/948203
Mar 28th, 2021 - CAPE TOWN (Reuters) - Parked on the roadside next to a graveyard in Cape Town's Gugulethu township, a tuberculosis hotspot, a team of health workers set up a makeshift TB screening room next to their van. Gladys Rara, 45, provides a sputum sample ...
https://www.cdc.gov/mmwr/volumes/70/wr/mm7012a1.htm
MMWR Morb Mortal Wkly; Deutsch-Feldman M, Pratt RH et. al.
Mar 25th, 2021 - Tuberculosis (TB) disease incidence has decreased steadily since 1993 (1), a result of decades of work by local TB programs to detect, treat, and prevent TB disease and transmission. During 2020, a total of 7,163 TB cases were provisionally report...
https://www.medscape.com/viewarticle/947195
Mar 9th, 2021 - Despite recent advances in the diagnosis, treatment, and prevention of pediatric tuberculosis in children living with HIV (CLHIV) and HIV-exposed uninfected children (HEU), several unmet needs remain, including studies evaluating the feasibility o...
https://www.medscape.com/viewarticle/947201
Mar 9th, 2021 - Long-acting injectable (LAI) drug formulations represent a promising new strategy for the prevention and treatment of tuberculosis in women and children, according to an online presentation at the Conference on Retroviruses & Opportunistic Infecti...
https://www.medscape.com/viewarticle/947111
Mar 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. In late February 2020, Martin Valencia Garcia was working as a community agent in Independencia, one of the denser districts of Lima, Peru. His jo...